Tiziana life sciences announces near-term strategic focus on intranasal foralumab for diseases of the central nervous system (cns)

-company to host conference call via webcast at 10 am et- -company to host conference call via webcast at 10 am et-

TLSA Ratings Summary

TLSA Quant Ranking